This is an application for years 11-15 to expand the Florida Node into the Florida Node Alliance (FNA) of NIDA's CTN. We are building on our past record of success in leading and co-leading CTN trials in the areas of family-based treatment/adolescents, HIV testing and counseling, interventions for Hispanic drug users, supporting our community treatment programs (CTPs) in participating in 7 CTN trials in the past 5 years, and leading regional dissemination activities. The collaboration between scientists and CTPs has been the foundation of our Node and is the mission of the FNA. The FNA has expanded in geography, scientific expertise, and type of participating CTP. We retain our five CTPs in Florida and have recruited CTPs in Colorado, Georgia, North Carolina, Puerto Rico, and the Virgin Islands. The FNA now incorporates internationally renowned researchers in the fields of adolescents/pediatrics, HIV, combined behavioral/pharmacological treatments, information technology, health economics, and physical activity. Our partnerships have been expanded to include emergency departments, sexually-transmitted-disease/public health clinics, and HIV Inpatient/outpatient care sites. Veterans Affairs facilities, and other primary care providers. We have a total of 48 CTPs in the FNA. FNA also has a major commitment to expanding CTN benefits to Latin America including mentoring and training the emerging Mexico CTN Node. Our research infrastructure supports the development and implementation of clinical trials to answer a broad spectrum of transitional research questions across a wide variety of treatment settings and diverse patient populations. Dissemination partners facilitate training in evidence-based treatments in our service areas. We propose a research agenda that will (1) blend substance abuse treatment within health care settings;(2) involve family members in the treatment of substance use disorders;(3) use information technologies to improve treatment attractiveness, quality, and cost-effectiveness;(4) combine pharmacotherapies and behavioral interventions, (5) use exercise to enhance treatment outcomes among adolescents, and (6) integrate HIV and other infectious disease testing in care settings commonly used by individuals with substance use disorders.

Public Health Relevance

The FNA will support the Office on National Drug Control Policy and NIDA initiatives to bring a range of health settings into the delivery of evidence based services for substance using individuals by providing a broad-reaching research infrastructure that (through bi-directional, transitional partnerships among community-based providers and scientists) will develop and implement practice-relevant clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
3U10DA013720-15S1
Application #
8909735
Study Section
Special Emphasis Panel (ZDA1)
Program Officer
Dobbins, Ronald
Project Start
2000-09-30
Project End
2015-08-31
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
15
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Miami School of Medicine
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
City
Coral Gables
State
FL
Country
United States
Zip Code
33146
Gooden, Lauren; Metsch, Lisa R; Pereyra, Margaret R et al. (2016) Examining the Efficacy of HIV Risk-Reduction Counseling on the Sexual Risk Behaviors of a National Sample of Drug Abuse Treatment Clients: Analysis of Subgroups. AIDS Behav 20:1893-906
Hernández, Diana; Feaster, Daniel J; Gooden, Lauren et al. (2016) Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients. AIDS Behav 20:204-14
Murphy, Sean M; Campbell, Aimee N C; Ghitza, Udi E et al. (2016) Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial. Drug Alcohol Depend 161:119-26
Feaster, Daniel J; Parish, Carrigan L; Gooden, Lauren et al. (2016) Substance use and STI acquisition: Secondary analysis from the AWARE study. Drug Alcohol Depend 169:171-179
Magee, Joshua C; Lewis, Daniel F; Winhusen, Theresa (2016) Evaluating Nicotine Craving, Withdrawal, and Substance Use as Mediators of Smoking Cessation in Cocaine- and Methamphetamine-Dependent Patients. Nicotine Tob Res 18:1196-201
Magee, Joshua C; Winhusen, Theresa (2016) The coupling of nicotine and stimulant craving during treatment for stimulant dependence. J Consult Clin Psychol 84:230-7
Metsch, Lisa R; Feaster, Daniel J; Gooden, Lauren et al. (2016) Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. JAMA 316:156-70
Sanchez, Katherine; Walker, Robrina; Campbell, Aimee N C et al. (2015) Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems. Subst Abus 36:297-303
Kyle, Tiffany L; Horigian, Viviana E; Tross, Susan et al. (2015) Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS Behav 19:536-42
Horigian, Viviana E; Feaster, Daniel J; Brincks, Ahnalee et al. (2015) The effects of Brief Strategic Family Therapy (BSFT) on parent substance use and the association between parent and adolescent substance use. Addict Behav 42:44-50

Showing the most recent 10 out of 95 publications